Hamel Associates’s iShares iBonds Dec 2024 Term Corporate ETF IBDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-273,500
Closed -$6.89M 77
2024
Q3
$6.89M Sell
273,500
-10,581
-4% -$266K 2.11% 20
2024
Q2
$7.14M Sell
284,081
-11,924
-4% -$299K 2.25% 19
2024
Q1
$7.41M Buy
296,005
+8,637
+3% +$216K 2.38% 17
2023
Q4
$7.16M Buy
287,368
+3,300
+1% +$81.8K 2.52% 14
2023
Q3
$7.03M Buy
284,068
+7,599
+3% +$187K 2.57% 12
2023
Q2
$6.81M Buy
276,469
+8,020
+3% +$197K 2.38% 14
2023
Q1
$6.6M Buy
268,449
+16,237
+6% +$398K 2.29% 16
2022
Q4
$6.16M Buy
252,212
+67,657
+37% +$1.65M 2.14% 18
2022
Q3
$4.49M Buy
+184,555
New +$4.56M 1.78% 21

Other funds holding IBDP

Hamel Associates's IBDP Position: Q4 2024 in Review

Hamel Associates sold out of iShares iBonds Dec 2024 Term Corporate ETF (IBDP) in Q4 2024, closing a stake of 273,500 shares — an estimated $6.89M sold.

Hamel Associates first reported a position in IBDP in Q3 2022 and held it in 9 quarters. The position peaked at $7.41M in Q1 2024. 2 funds tracked by Wall St. Rank hold IBDP as of Q4 2024.

  • Hamel Associates reported no remaining iShares iBonds Dec 2024 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
  • Hamel Associates sold 273,500 iShares iBonds Dec 2024 Term Corporate ETF shares in Q4 2024, an estimated $6.89M.
  • Hamel Associates first reported a position in iShares iBonds Dec 2024 Term Corporate ETF in Q3 2022 and held it in 9 quarters.
  • Hamel Associates's iShares iBonds Dec 2024 Term Corporate ETF position peaked at $7.41M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Corporate ETF as of Q4 2024.

Based on Hamel Associates's 13F filing for Q4 2024, filed 5 Feb 2025.